Postauricular percutaneous power delivery for permanent mechanical circulatory support

Westaby, Stephen; Jarvik, Robert; Freeland, A. P.; Pigott, David; Robson, D.; Saito, Satoshi; Catarino, Pedro; Frazier, O.H.

doi:10.1067/mtc.2002.121045

Cited by 52 publications

(51 citation statements)

References 12 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The two case series of the Jarvik 2000 LVAD examined adverse events (Table 21 and Appendix 16). [94][95][96][97][98][99][100] Frazier and colleagues' 94 case series of three patients with a Jarvik 2000 LVAD as a BTT found localised infection of the powercable exit site in one patient. There were no device-related medical problems.…”

Section: Second-generation Lvadsmentioning

confidence: 99%

“…Two case series of the Jarvik 2000 LVAD reported survival to transplantation (Table 17 and Appendix 16). [94][95][96][97][98][99][100] In a case series 94 of three patients, a successful heart transplant rate of 67% was reported with one patient still awaiting transplant. A multicentre case series study, which also assessed patients supported long term with LVAD (see the section 'LVADs as a long-term chronic support' p. 58), reported survival to heart transplantation for 22 patients with the indication of BTT.…”

Section: Second-generation Lvadsmentioning

confidence: 99%

“…A multicentre case series study, which also assessed patients supported long term with LVAD (see the section 'LVADs as a long-term chronic support' p. 58), reported survival to heart transplantation for 22 patients with the indication of BTT. [95][96][97][98][99][100] Of these, 13 patients underwent heart transplant, seven patients had died and two patients continued to be supported by the device.…”

Section: Second-generation Lvadsmentioning

confidence: 99%

“…One study of the Jarvik 2000 LVAD focused on males (66%) with a mean age of 47 years and suffering from ischaemic aetiology, 94 whereas in the other case study patient ages ranged from 30 to 70 years, 73% were male and 50% suffered from dilated cardiomyopathy and 50% from ischaemic cardiomyopathy. [94][95][96][97][98][99][100] The patients in the MicroMed DeBakey studies range in age from 33 to 65 years and were predominantly male. The case studies of the Thoratec LVAD each reported male patients.…”

Section: Generalisabilitymentioning

confidence: 99%

“…Two case series studies evaluating the Jarvik 2000 LVAD were judged to be methodologically weak, [94][95][96][97][98][99][100] with poor reporting of the selection criteria for participants and the methods of data collection (Appendix 16). Outcome assessment was not blinded, providing the opportunity for ascertainment bias.…”

Section: Jarvikmentioning

confidence: 99%

See 4 more Smart Citations

Cost–effectiveness of left ventricular-assist devices in end-stage heart failure

Hutchinson¹,

Scott²,

Clegg³

et al. 2008

Expert Review of Cardiovascular Therapy

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTAThe clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA Programme commissions research only on topics...

show abstract

Section: Second-generation Lvadsmentioning

confidence: 99%

Section: Second-generation Lvadsmentioning

confidence: 99%

Section: Second-generation Lvadsmentioning

confidence: 99%

Section: Generalisabilitymentioning

confidence: 99%

Section: Jarvikmentioning

confidence: 99%

See 3 more Smart Citations

Cost–effectiveness of left ventricular-assist devices in end-stage heart failure

Hutchinson¹,

Scott²,

Clegg³

et al. 2008

Expert Review of Cardiovascular Therapy

View full text Add to dashboard Cite

show abstract

Artificial Heart

Takatani

2006

Wiley Encyclopedia of Biomedical Engineering

View full text Add to dashboard Cite

The artificial heart (AH) is a mechanical pump that partially or completely replaces the pumping function of the native heart. Two types of AH exist depending on use. The first is called ventricular assist device (VAD) and consists of a single pump to help the pumping function of the left or right ventricle, or both ventricles by combining two VADs without removing the native heart. The second AH is called total artificial heart (TAH) and is comprised of two pumps to maintain both lung circulation and systemic circulation after removal of the native heart.

show abstract